Amplify Therapeutics ApS — Credit Rating and Financial Key Figures

Amplify Therapeutics ApS (CVR number: 43803999) is a company from KØBENHAVN. The company recorded a gross profit of -4961.5 kDKK in 2024. The operating profit was -8280.5 kDKK, while net earnings were -7194.9 kDKK. The profitability of the company measured by Return on Assets (ROA) was -84.3 %, which can be considered poor and Return on Equity (ROE) was -167.8 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -60.5 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. Amplify Therapeutics ApS's liquidity measured by quick ratio was 13.1 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.